Shionogi Inc. is the U.S. arm of a pharmaceutical company that develops and sells medicines. Its filings show it lobbies Congress mainly on pandemic preparedness and antimicrobial resistance, including support for the PASTEUR Act (bills H.R. 3932 and S. 2076), and on pharmacy, research/clinical labs, insurance, and budget issues. The company did this work directly without outside firms.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JOHN BILLINGTON
The latest disclosures for this client.
SHIONOGI INC.
Q2SHIONOGI INC.
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
SHIONOGI INC.
EDWWARD BUCKLEY
SHIONOGI INC.
SHIONOGI INC.
Q4SHIONOGI INC.
RASHIONOGI INC.
1T